Clinical trial NCT00687492: Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Official title: Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hypercholesterolemia
Keywords: hypercholesterolemia
NCEP ATP III guidelines
survey
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-05-30
Enrollment: 8000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients had to be on a lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Brief summary: The survey will try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the third NCEP ATP guidelines, overall and by country.


Eligibility criteria: Inclusion Criteria:

* 2 or more risk factors (according to NCEP ATP III guideline)
* Receiving lipid-lowering drug treatment for at least 3 months without dosage change for a minimum of 6 weeks.

Exclusion Criteria:

* Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
* Previous enrolment or randomisation of treatment in the present study.
* Participation in a clinical study during the last 90 days.

Primary outcomes:
measure: The number and percentage of subjects achieving the LDL-C goals according to updated 2004 NCEP ATP Ⅲ guidelines(overall and by country)
timeFrame: After collecting all Patient Record Form.
Secondary outcomes:
measure: The number and percentage of subjects achieving the LDL-C goals according to the updated 2004 NCEP ATP Ⅲ guidelines for several subject subsets.
timeFrame: After collecting all Patient Record Form.
measure: The association between achievement of LDL-C goals,according to the updated 2004 NCEP ATPⅢ guidelines and patient and physician variables.
timeFrame: After collecting all Patient Record Form.
measure: The physician characteristics associated with the allocation of hypercholesterolemia treatment regime.
timeFrame: After collecting all Patient Record Form.
Other outcomes:
Locations:
city: Hong Kong
country: China
facility: Research Site
state: Hong Kong
city: Semarang
country: Indonesia
facility: Research Site
state: Central Java
city: Jakarta
country: Indonesia
facility: Research Site
state: DKI Jakarta
city: Sidoarjo
country: Indonesia
facility: Research Site
state: East Java
city: Surabaya
country: Indonesia
facility: Research Site
state: East Java
city: Medan
country: Indonesia
facility: Research Site
state: North Sumatra
city: Bandung
country: Indonesia
facility: Research Site
state: West Java
city: Cheon-an
country: Korea, Republic of
facility: Research Site
state: Chung-Cheong-nam-do
city: Bu-cheon
country: Korea, Republic of
facility: Research Site
state: Gyeong-gi
city: Bundang
country: Korea, Republic of
facility: Research Site
state: Gyeong-gi
city: Gu-ri
country: Korea, Republic of
facility: Research Site
state: Gyeong-gi
city: Il-san
country: Korea, Republic of
facility: Research Site
state: Gyeong-gi
city: Su-won
country: Korea, Republic of
facility: Research Site
state: Gyeong-gi
city: Ma-san
country: Korea, Republic of
facility: Research Site
state: Gyung-sang-nam-do
city: Bu-san
country: Korea, Republic of
facility: Research Site
city: Dae-gu
country: Korea, Republic of
facility: Research Site
city: Dae-jeon
country: Korea, Republic of
facility: Research Site
city: Gwangju
country: Korea, Republic of
facility: Research Site
city: In-cheon
country: Korea, Republic of
facility: Research Site
city: Je-ju
country: Korea, Republic of
facility: Research Site
city: Seoul
country: Korea, Republic of
facility: Research Site
city: Ul-san
country: Korea, Republic of
facility: Research Site
city: Bangsar
country: Malaysia
facility: Research Site
state: Kuala Lumpur
city: Kepong
country: Malaysia
facility: Research Site
state: Kuala Lumpur
city: Puchong
country: Malaysia
facility: Research Site
state: Kuala Lumpur
city: Setapak
country: Malaysia
facility: Research Site
state: Kuala Lumpur
city: Ampang
country: Malaysia
facility: Research Site
state: Selangor
city: Bandar Sunway
country: Malaysia
facility: Research Site
state: Selangor
city: Batu Caves
country: Malaysia
facility: Research Site
state: Selangor
city: Hulu Selangor
country: Malaysia
facility: Research Site
state: Selangor
city: Klang
country: Malaysia
facility: Research Site
state: Selangor
city: Petaling Jaya
country: Malaysia
facility: Research Site
state: Selangor
city: Port Klang
country: Malaysia
facility: Research Site
state: Selangor
city: Sekinchan
country: Malaysia
facility: Research Site
state: Selangor
city: Seri Kembangan
country: Malaysia
facility: Research Site
state: Selangor
city: Shah Alam
country: Malaysia
facility: Research Site
state: Selangor
city: Subang Jaya
country: Malaysia
facility: Research Site
state: Selangor
city: Subang
country: Malaysia
facility: Research Site
state: Selangor
city: Sungai Buloh
country: Malaysia
facility: Research Site
state: Selangor
city: Kuala Lumpur
country: Malaysia
facility: Research Site
city: Selangor
country: Malaysia
facility: Research Site
city: Lipa
country: Philippines
facility: Research Site
state: Batangas
city: Baguio
country: Philippines
facility: Research Site
state: Benguet
city: Davao
country: Philippines
facility: Research Site
city: Iloilo
country: Philippines
facility: Research Site
city: Manila
country: Philippines
facility: Research Site
city: Kaohsiung
country: Taiwan
facility: Research Site
city: Taichung
country: Taiwan
facility: Research Site
city: Tainan
country: Taiwan
facility: Research Site
city: Taipei
country: Taiwan
facility: Research Site
city: Taoyuan
country: Taiwan
facility: Research Site
city: Bangkoknoi
country: Thailand
facility: Research Site
state: Bangkok
city: Dusit
country: Thailand
facility: Research Site
state: Bangkok
city: Pathumwan
country: Thailand
facility: Research Site
state: Bangkok
city: Ratchathewi
country: Thailand
facility: Research Site
state: Bangkok
city: Muang
country: Thailand
facility: Research Site
state: ChiangMai
city: Klongluang
country: Thailand
facility: Research Site
state: Pathumthani
city: Hanoi
country: Vietnam
facility: Research Site
city: Hcmc
country: Vietnam
facility: Research Site
Study officials:
affiliation: Sungkyunkwan University
name: Park Jeong Euy
role: PRINCIPAL_INVESTIGATOR
References: